Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein

EU orphan designation number: EU/3/05/317   
Active ingredient: A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein
Indication: Treatment of graft-versus-host disease
Sponsor: Xenikos B.V.
Molenveldlaan 152 A, NL-6523 RN Nijmegen, Nederlnad

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Orphan Designation EMEA/OD/046/05 (2005)3341 of 26/08/2005
12/01/2010 Transfer of orphan designation EMEA/OD/046/05/T/01 (2010)71 of 08/01/2010
30/09/2010 Corrigendum (2010)6815 of 28/09/2010
05/12/2012 Change of address of sponsor